• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells
 

Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells

Options
  • Details
Publisher DOI
10.1161/CIRCULATIONAHA.111.042598
PubMed ID
22086878
Description
Cardiosphere-derived cells (CDCs) are an attractive cell type for tissue regeneration, and autologous CDCs are being tested clinically. However, autologous therapy necessitates patient-specific tissue harvesting and cell processing, with delays to therapy and possible variations in cell potency. The use of allogeneic CDCs, if safe and effective, would obviate such limitations. We compared syngeneic and allogeneic CDC transplantation in rats from immunologically-mismatched inbred strains.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
Malliaras, Konstantinos
Li, Tao-Sheng
Luthringer, Daniel
Terrovitis, John
Cheng, Ke
Chakravarty, Tarun
Galang, Giselle
Zhang, Yiqiang
Schönhoff, Florian
Universitätsklinik für Herz- und Gefässchirurgie
Van Eyk, Jennifer
Marbán, Linda
Marbán, Eduardo
Additional Credits
Universitätsklinik für Herz- und Gefässchirurgie
Series
Circulation
Publisher
Lippincott Williams & Wilkins
ISSN
0009-7322
Access(Rights)
metadata.only
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo